Sagittarius Life Science Corp.
Records under this name other than the patents Sagittarius Life Science Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 6 of 6 · Back to Sagittarius Life Science Corp.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,709,538 | ST104P, an anti-angiogenic agent Term ended Term ended Aug 3, 2024 · USPTO record | Term ended | Term ended Aug 3, 2024 | USPTO record |
| US 7,459,173 | Medicament for prevention and treatment of bone fracture and osteoporosis Term ended Term ended Apr 19, 2024 · USPTO record | Term ended | Term ended Apr 19, 2024 | USPTO record |
| US 6,586,016 | ST 188L as the prevention and treatment for cancers and infections Term ended Term ended Sep 13, 2021 · USPTO record | Term ended | Term ended Sep 13, 2021 | USPTO record |
| US 7,273,890 | ST104P, an anti-angiogenic agent Lapsed on the fee record Ended Sep 25, 2019 · USPTO record | Lapsed on the fee record | Ended Sep 25, 2019 | USPTO record |
| US 6,352,715 | Transdermal rate-controlled delivery of Huperzine A for treatment of alzheimer's disease Term ended Term ended Feb 19, 2018 · USPTO record | Term ended | Term ended Feb 19, 2018 | USPTO record |
| US 7,134,978 | Seamless BB paintball Formerly held Lapsed on the fee record Ended Nov 14, 2014 · USPTO record | Lapsed on the fee record | Ended Nov 14, 2014 | USPTO record |